Skip to main content

Month: May 2020

2020 nr. 8 – Sanistål offentliggør kvartalsorientering for 1. kvartal 2020

                                                                                Kontaktperson:                                                                                                                                Adm. direktør                                                                                                                                Christian B. Lund                                                                                                                Tlf. 96 30 60 00Aalborg, den 27. maj 2020Bestyrelsen har i dag godkendt kvartalsorienteringen for 1. kvartal 2020 (Se vedhæftede fil) med følgende hovedpunkter:Resultaterne i 1. kvartal var påvirket af COVID-19 krisen, blandt andet med forskydninger af salget i Danmark over mod produkter og kunder med lavere marginer.Omsætningen i 1. kvartal faldt 3% til...

Continue reading

DraftKings Announces Redemption of Public Warrants

BOSTON, May 27, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that it will redeem all of its outstanding public warrants to purchase shares of DraftKings’ Class A common stock that were issued under the Warrant Agreement, dated as of May 10, 2019 (the “Warrant Agreement”), by and among Diamond Eagle Acquisition Corp. and Continental Stock Transfer & Trust Company, as warrant agent and transfer agent (as assigned to and assumed by DraftKings and Computershare Trust Company, N.A., a federally chartered trust company, and Computershare Inc., a Delaware corporation (collectively, “Computershare”), as warrant agent and transfer agent, pursuant to that certain Assignment and Assumption Agreement, dated as of April 23, 2020), and that remain outstanding following 5:00 p.m. New York City time on June 26, 2020...

Continue reading

Black Diamond Therapeutics to Present at the Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass. and NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s business at the Jefferies Virtual Healthcare Conference. The presentation will take place on Wednesday, June 3, 2020, at 1:30 PM ET.A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks.About Black DiamondBlack Diamond Therapeutics is a precision oncology medicine company pioneering...

Continue reading

Ferrari Announces Settlement of its Notes offering  

Maranello (Italy), 27 May 2020 – Ferrari N.V. (NYSE/MTA: RACE) announces the settlement of the offering, previously announced, of Euro 650 million in aggregate principal amount of 1.500% notes due in May 2025, with an issue price of 98.898% (the “Notes”). The net proceeds of the offering were approximately Euro 641 million after payment of offering and related expenses. The Notes have been admitted to the Official List of Euronext Dublin and to trading on the regulated market of Euronext Dublin.The prospectus related to the Notes, dated 21 May 2020, was approved by the Central Bank of Ireland and it has been published on the Ferrari N.V. corporate website together with other relevant documents.AttachmentFNV 2020 DRS – Settlement PR (ENG) Final

Continue reading

Trius Announces Stock Option Grant

FREDERICTON, New Brunswick , May 27, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV:TRU.H) (“Trius”) announces that, subject to regulatory approval, it has granted an aggregate of 950,000 incentive stock options (“Options”) to its independent directors in accordance with Trius’ stock option plan. These Options have a five-year term and an exercise price of $0.105 each, and vest immediately. The Options, and any common shares of Trius that may be issued upon their exercise, are subject to a hold period expiring four months and one day after the date of grant of the Options.About Trius Investments Inc.Trius is an investment issuer searching for new investments and/or business opportunities. Trius’ common shares trade on the NEX Board of the TSX Venture Exchange under the symbol “TRU.H”.Trius is a portfolio company of Resurgent...

Continue reading

Par Pacific Holdings Announces Private Offering of $100 Million of Senior Secured Notes Due 2026

HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today announced that Par Petroleum, LLC (“Par Petroleum”) and Par Petroleum Finance Corp. (“Finance Corp.” and together with Par Petroleum, the “Issuers”), both wholly-owned subsidiaries of the Company, intend to offer, subject to market and other conditions, $100 million aggregate principal amount of senior secured notes due 2026 (the “Notes”) through a private offering to qualified institutional buyers pursuant to Rule 144A and to certain persons outside of the United States pursuant to Regulation S, each under the Securities Act of 1933, as amended (the “Act”).     The Notes will be secured, senior obligations of the Issuers, and interest will be payable semi-annually in arrears. The Notes will be guaranteed on a...

Continue reading

Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med EAC Invest A/S’ aktier og tilknyttede værdipapirer – Selskabsmeddelelse nr. 19/2020

København, 27. maj 2020I henhold til artikel 19 i EU Regulativ nr. 596/2014 af 16. april 2014 skal EAC Invest A/S indberette oplysninger om ledende medarbejderes og disses nærtståendes transaktioner med EAC Invest A/S’ aktier og tilknyttede værdipapirer.Detaljer fremgår af vedhæftede.Med venlig hilsen,for EAC Invest A/SBestyrelsenFor yderligere informationMartin Thaysen, CEO, Telefon: +45 3525 4300, e-mail investorinformation@eac.dkVedhæftede filerPDMR – Olav W. Hansen AS – 26.05.2020PDMR – Olav W. Hansen AS – 25.05.2020

Continue reading

Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference

WEST CHESTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will virtually present at the Jefferies 2020 Healthcare Conference. Details for the presentation are included below:Jefferies 2020 Healthcare ConferenceTuesday, June 2nd3:30 PM – 3:55 PM ETA live webcast of the presentation can be accessed at the company’s Investors page under Events and Presentations at https://investors.verrica.com/events-and-presentations.  Webcast replay will also be available on this website shortly after conclusion of the event for 30 days.About Verrica Pharmaceuticals Inc.Verrica is a dermatology therapeutics company developing...

Continue reading

Bellicum to Participate in Two Upcoming Virtual Investor Conferences

HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual investor conferences.Conference Details:Jefferies Virtual Healthcare ConferenceDate/Time: Wednesday, June 3, 2020 at 4:00 p.m. EDTFormat: Fireside ChatInvestor Summit Virtual Summer SummitDate/Time: Wednesday, June 10, 2020 at 3:20 p.m. EDTFormat: PresentationLive webcasts of the fireside chat and presentation may be accessed from the Events & Presentation section of the Bellicum website. An archived version of each webcast will be available for replay immediately following the event.About Bellicum PharmaceuticalsBellicum is a clinical stage biopharmaceutical company striving to deliver...

Continue reading

The Lovesac Company to Announce First Quarter Fiscal 2021 Earnings Results

STAMFORD, Conn., May 27, 2020 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) today announced that its financial results for the first quarter of fiscal 2021 will be released before market open on Tuesday, June 9, 2020. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-6780) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.lovesac.com.A recorded replay of the conference call will be available within two hours of the conclusion of the call and can be accessed online at investor.lovesac.com for 90 days.About The Lovesac CompanyBased in Stamford, Connecticut,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.